Risk factors
Cytek Biosciences (CTKB) risk factors
Item 1A of every Cytek Biosciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors69 risks13 new7 dropped15 reworded
Cytek added new risk disclosures regarding trade tariffs, AI technology integration, and material weaknesses in internal controls for 2024.
Filed Feb 26, 2026 - FY2024 10-K risk factors63 risks
Cytek Biosciences faces strong reliance on a limited number of core flow cytometry systems like Cytek Aurora. International expansion exposes the company to complex regulatory and trade policy risks. Academic and government institutional spending heavily dictates future revenue and research success.
Filed Feb 28, 2025